In January 2025, Paul Dworak and Storms Dworak teamed up with Dillon White and Messerli Kramer in the Depo-Provera litigation—an injectable birth control that has been linked by the FDA to meningioma brain tumors. Although often classified as benign, these tumors can cause devastating harm—frequently requiring brain surgery and resulting in lasting complications such as chronic migraines, memory loss, blindness, seizures, and, in some cases, death.
From the outset, our firms committed the time and resources necessary to pursue justice and accountability for these brave women. For us, that means meeting with clients, filing lawsuits on their behalf, and actively litigating their claims so their stories are heard through the legal process.
We have filed over 100 federal lawsuits against Pfizer—and we are just getting started.
About the Depo-Provera Litigation:
The Depo-Provera litigation involves claims brought by women who allege they developed meningioma brain tumors after using the injectable contraceptive Depo-Provera. These lawsuits assert that Pfizer failed to adequately warn patients and healthcare providers about potential risks associated with long-term use of the drug. Pfizer has denied wrongdoing, and the claims remain contested.
In February 2025, the Judicial Panel on Multidistrict Litigation centralized federal cases into MDL No. 3140 in the U.S. District Court for the Northern District of Florida before Judge M. Casey Rodgers. The MDL consolidates cases with common factual questions—such as causation, knowledge of risk, and adequacy of warnings—to streamline pretrial proceedings while allowing each plaintiff to maintain an individual claim.
As of December 2025, the FDA requires Pfizer to include warnings about meningiomas.
The litigation is ongoing, with courts overseeing coordinated discovery, motion practice, and other pretrial matters to evaluate the parties’ claims and defenses.